← Leaderboards
David Lee Williams
Illinois State University
$5,118,931
Attributed
$7,845,044
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $880.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,845,044 · 14
By mechanism
R21$3,224,789 · 8
R01$2,989,304 · 2
R33$1,346,661 · 1
R03$144,290 · 2
R15$140,000 · 1
Top collaborators
- Pavel A Petukhov11 shared
- Gregory R J Thatcher5 shared
- Francesco Angelucci4 shared
Others in their field
Top investigators on “Schistosomiasis”
- Jeffrey S Akman · George Washington University$15,000,000
- Edward J. Pearce · Cornell University Ithaca$11,346,993
- Jennifer F Friedman · Rhode Island Hospital$11,028,389
- Miguel J. Stadecker · Tufts University Boston$8,764,073
- James J Collins · Ut Southwestern Medical Center$8,321,594
- Brian Barkley Graham · University Of Colorado Denver$7,546,061
Research focus
SchistosomiasisPharmaceutical PreparationsCessation Of LifeSchistosomaDrug ResistancePraziquantelDrug DevelopmentSchistosoma MansoniEnzymesChemotherapyDesignTransmission ProcessBiochemicalProteinsParasitesBaseLeadNeglectToxic EffectInhibitor/AntagonistStructureGlutathione ReductaseMammalian CellCollaborations
Grant awards (32)
Development of novel TGR inhibitors for the treatment of schistosomiasis$767,020
R01 · FY2025 · AI
Development of novel TGR inhibitors for the treatment of schistosomiasis$800,624
R01 · FY2024 · AI
Discovery of novel smHDAC8 inhibitors for the treatment of schistosomiasis$230,492
R21 · FY2022 · AI
Identification of the target of meclonazepam in schistosome worms$196,975
R21 · FY2022 · AI · contact PI
Identification of preclinical drug candidates for the treatment of schistosomiasis$412,893
R33 · FY2021 · AI · contact PI
Identification of the target of meclonazepam in schistosome worms$251,200
R21 · FY2021 · AI · contact PI
Discovery of novel smHDAC8 inhibitors for the treatment of schistosomiasis$216,651
R21 · FY2021 · AI
Identification of preclinical drug candidates for the treatment of schistosomiasis$443,078
R33 · FY2020 · AI · contact PI
Identification of preclinical drug candidates for the treatment of schistosomiasis$490,690
R33 · FY2019 · AI · contact PI
Identification of preclinical drug candidates for the treatment of schistosomiasis$169,545
R21 · FY2018 · AI · contact PI
Identification of preclinical drug candidates for the treatment of schistosomiasis$222,045
R21 · FY2017 · AI · contact PI
Deorphanization of Schistosome Cytochrome P450$193,750
R21 · FY2017 · AI · contact PI
Deorphanization of Schistosome Cytochrome P450$232,500
R21 · FY2016 · AI · contact PI
Development of a functional genomics toolbox for schistosome parasites$191,250
R21 · FY2013 · AI · contact PI
Development of a functional genomics toolbox for schistosome parasites$200,350
R21 · FY2012 · AI · contact PI
Redox Balance & Drug Development in Schistosoma mansoni$260,401
R01 · FY2011 · AI · contact PI
Redox Balance & Drug Development in Schistosoma mansoni$263,031
R01 · FY2010 · AI · contact PI
Is phytochelatin synthase an essential enzyme and drug target for schistosomiasis$187,500
R21 · FY2010 · AI · contact PI
Redox Balance & Drug Development in Schistosoma mansoni$265,688
R01 · FY2009 · AI · contact PI
Is phytochelatin synthase an essential enzyme and drug target for schistosomiasis$225,000
R21 · FY2009 · AI · contact PI
Redox Balance & Drug Development in Schistosoma mansoni$75,000
R01 · FY2009 · AI · contact PI
Redox Balance & Drug Development in Schistosoma mansoni$188,237
R01 · FY2008 · AI · contact PI
Redox Balance & Drug Development in Schistosoma mansoni$79,803
R01 · FY2008 · AI · contact PI
Redox Balance & Drug Development in Schistosoma mansoni$289,500
R01 · FY2007 · AI · contact PI
Mechanisms of anti-schistosome artemisinin chemotherapy$205,065
R21 · FY2006 · AI · contact PI
Developmental Gene Regulation in Schistosoma mansoni$173,524
R21 · FY2006 · AI · contact PI
Mechanisms of anti-schistosome artemisinin chemotherapy$175,000
R21 · FY2005 · AI
Developmental Gene Regulation in Schistosoma mansoni$153,942
R21 · FY2005 · AI
High Throughput Proteome Analysis of Schistosoma mansoni$70,000
R03 · FY2005 · AI
HTS Inhibitors:Schistosoma Mansoni Peroxiredoxins(RMI)$4,290
R03 · FY2005 · MH
High Throughput Proteome Analysis of Schistosoma mansoni$70,000
R03 · FY2004 · AI
Disulfide redox balance in Schistosoma mansoni$140,000
R15 · FY2003 · AI